EGenesis Company
EGenesis focuses on leveraging genome editing technology to deliver safe and effective human transplantable cells, tissues, and organs.
Investors
.png)
Industry:
Geroscience
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
1/1/2014
Employees Number:
11-50
Funding Status:
Late Stage Venture
Investors Number:
27
Total Funding:
265000000
Estimated Revenue:
$10M to $50M
Last Funding Date:
2021
Last Funding Type:
Series C
Register and Claim Ownership